Stay updated on SB17 vs Stelara in Plaque Psoriasis Clinical Trial
Sign up to get notified when there's something new on the SB17 vs Stelara in Plaque Psoriasis Clinical Trial page.

Latest updates to the SB17 vs Stelara in Plaque Psoriasis Clinical Trial page
- Check4 days agoChange DetectedA sitewide NIH announcement about website updates and the use of “Super Intelligence” terminology appears above the 403 error page. The site revision changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe ClinicalTrials.gov footer revision number changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check32 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study content, replacing the study record with an access-denied message and removing visible study details.SummaryDifference17%

- Check39 days agoChange DetectedThe page now displays Revision: v3.7.0, replacing the previous Revision: v3.6.6. This indicates an updated version of the page used for tracking changes, with likely backend or layout updates rather than changes to study information.SummaryDifference0.0%

- Check53 days agoChange DetectedThe page revision has been updated to v3.6.6, indicating a small maintenance update to the ClinicalTrials.gov entry rather than a change to the trial details.SummaryDifference0.0%

- Check74 days agoChange DetectedThe page shows a new revision label, updating from v3.6.4 to v3.6.5.SummaryDifference0.0%

Stay in the know with updates to SB17 vs Stelara in Plaque Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SB17 vs Stelara in Plaque Psoriasis Clinical Trial page.